Life Sciences

With developing markets on the rise and new breakthroughs in pharmaceuticals, strategy is pivotal.  We will help your company navigate new opportunities, mitigate risks, and provide a better understanding of your company’s narrative in the industry.

Pharmacists as Vaccinators: New Entrant Disruption in Healthcare

While getting a flu vaccine in your local pharmacy is commonplace, other vaccines are becoming available as well.

Download White Paper

Transparency into Drug Pricing: Can it help with the high drug costs

Congress's initiative to create transparency into drug pricing won’t necessarily address the issue of high drug costs.

Read Blog Post

Increasing Drug Impact Through Patient Support Programs

It has become increasingly important for drug companies to develop and redesign patient support programs to increase product loyalty.


Download White Paper

Patient Compliance: The Next Challenge in Healthcare Innovation

Patient compliance has proven to involve more than just the pharmaceutical companies developing the drugs.

Download White Paper

Product Launch Pitfalls

Fuld + Company analyzed the most common pitfalls that have hampered dozens of product launches.


Download White Paper

Ascent of Amazon: From Books to…Pills?

Amazon recently reached its 20th anniversary this May. It was reported that it had intentions of delving into the multi-billion-dollar pharmacy market.


Read Blog Post

Quality Drug Data Not a Guarantee of Future Revenue

Despite having positive cardiovascular outcomes data, Amgen's PCSK9 inhibitor, Repatha will not sway payers if the cost-benefit ratio is too high.

Read Blog Post

The Ever Shifting Pharmaceutical Marketplace – Biosimilars and Interchangeability

Understand the differences between biosimilars and interchangeable pharmaceuticals and how to compete in this extremely crowded marketplace

Read Blog Post

Check out our Pharma blog posts!

Go see what our top analysts have top say about the Pharmaceutical industry and other healthcare-related topics